Analytical Development

ABR has successfully developed analytical methods utilizing high pressure liquid chromatography, mass spectroscopy and ultraviolet spectometry to  analyze the content of our active pharmaceutical ingredient (API) within our drug formulas, in urine and in blood plasma.  These methods have never been previously developed.  ABR is the first company to work out the procedural techniques for this specific API analyses.